Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01283126 · ClinicalTrials.gov registry record · NA
Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01283126 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 20 participants.
The verdict
NCT01283126, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to find out the effects of hypoglycemia on cognition in healthy individuals and how well changes in (interstitial) tissue glucose levels correlate with changes in cognitive function as compared to blood glucose levels.
Interventions
- PROCEDURE euglycemic and hypoglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-01 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01283126
The ClinicalTrials.gov registry entry for NCT01283126 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which euglycemic and hypoglycemic clamp is the first listed.
NCT01283126 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01283126 about?
NCT01283126 is a clinical study titled "Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery". The purpose of this study is to find out the effects of hypoglycemia on cognition in healthy individuals and how well changes in (interstitial) tissue glucose levels correlate with changes in cognitive function as compared to blood glucose levels.
What is the current status of trial NCT01283126?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-01. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01283126?
The interventions under investigation include: euglycemic and hypoglycemic clamp (PROCEDURE).
Who is sponsoring clinical trial NCT01283126?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.